ArrayExpress Gene Expression Atlas home | about the project | faq | feedback | blog | das | api new | help
NAGLU Homo sapiens
NAGLU is differentially expressed in 93 experiments [95 up/87 dn]: 14 organism parts: caudate nucleus [1 up/0 dn], kidney [1 up/0 dn], ...; 30 disease states: normal [3 up/4 dn], epilepsy [0 up/1 dn], ...; 23 cell types, 27 cell lines, 22 compound treatments and 18 other conditions.
Synonyms NAGLU, UFHSD1, hCG_16571, ufHSD2
Orthologs Naglu (Rattus norvegicus)  K09E4.4 (Caenorhabditis elegans)  CG13397 (Drosophila melanogaster)  Naglu (Mus musculus)  (Compare orthologs)
InterPro Term Alpha-N-acetylglucosaminidase
Diseases Sanfilippo syndrome, type B
GO Terms alpha-N-acetylglucosaminidase activity, glycosaminoglycan metabolic process, lysosome, nervous system development
Uniprot P54802  Q14769  Q59FD0 
Search EB-eye ENSG00000108784
REST API
Expression Summary
160 factor values, click each to filter
Factor Value Factor Up/Down
Legend: - number of studies the gene is up/down in
None Compound treatment
3
4
Normal Disease state
4
3
FLAP Compound treatment
2
MK886 Compound treatment
2
HNRPA2B Compound treatment
2
HeLa Cell line
2
Monocyte Cell type
1
1
Epithelial cell Cell type
2
Uninfected Infection
2
Endothelial cell Cell type
1
1
HL-60 Cell line
1
1
Caco-2 Cell line
1
1
PC3 Cell line
1
SKMEL5 Cell line
1
Glucocorticoid resistant Phenotype
1
Pretreatment primary sample Clinical info
1
Epilepsy Disease state
1
Grade IV Tumor grading
1
Caudate nucleus Organism part
1
Glioblastoma Disease state
1
Glucocorticoid sensitive Phenotype
1
Kidney Organism part
1
Peripheral blood Organism part
1
Plasma cell Cell type
1
B lymphocyte Cell type
1
Rapamycin Compound treatment
1
X-linked chronic granulomatous Disease state
1
Epidermal growth factor Compound treatment
1
Lymphatic endothelial cell Cell type
1
Control for heregulin Compound treatment
1
Cerebellum Organism part
1
PCep4 control vector transfect... Gene modification
1
ETat plasmid transfection Gene modification
1
White blood cells Organism part
1
HPL1 Cell line
1
Affymetrix Labeling Protocol type
1
T47D Cell line
1
Idiopathic dilated cardiomyopa... Disease state
1
MCF-7 Cell line
1
Endometrioid carcinoma Disease state
1
Dimethyl sulfoxide Compound treatment
1
MDA468 Cell line
1
MCF10A Cell line
1
Malignant melanoma Disease state
1
SkinEthic keratinocyte Cell type
1
Epidermal keratinocyte Cell type
1
Jurkat Cell line
1
Stage II Disease staging
1
TIVE Cell line
1
Neutrophil Cell type
1
KSHV latent infection Disease state
1
Experimental malaria-infected Disease state
1
Trichostatin A Compound treatment
1
Chronic lymphocytic leukemia Disease state
1
T47-D Cell line
1
Multiple myeloma Disease state
1
Selenium Compound treatment
1
Superficial transitional cell ... Disease state
1
Frontal cortex, superior motor... Organism part
1
Arsenic oxide Compound treatment
1
Skeletal muscle Organism part
1
Control RNAi
1
SIM2s RNAi
1
MDA-MB-231 Cell line
1
Heregulin Compound treatment
1
Superficial transitional cell ... Disease state
1
CD34+ Cell type
1
Fibroblast Cell type
1
SsMCF7 Cell line
1
Invasive ductal carcinoma Histology
1
Tumor Organism part
1
Granulocyte Cell type
1
Stromal cell Cell type
1
Whole blood Organism part
1
Ciliary ganglion Organism part
1
Stage I Disease staging
1
Breast carcinoma Disease state
1
Geriatric Developmental stage
1
Pediatric Developmental stage
1
Methotrexate Compound treatment
1
Burkitt's lymphoma Disease state
1
Placebo Compound treatment
1
N/a Test result
1
Secretory cell Cell type
1
Macrophage Cell type
1
Treated malaria, natural infec... Disease state
1
Metastatic Disease staging
1
Gorilla gorilla Organism
1
Mannitol Compound treatment
1
Adipose-derived stem cell Cell type
1
Enzo Labeling Protocol type
1
Organism_part Material type
1
Cell Material type
1
T-cell acute lymphoblastic leu... Disease state
1
Not applicable Histology
1
BT-474 Cell line
1
0 cm away from the tumor bound... Observation
1
BL41K3 Cell line
1
BJABK3 Cell line
1
Kaposi's sarcoma-associated he... Infection
1
HaCaT Cell line
1
Carcinoma in situ lesion Disease state
1
Non-ischemic cardiomyopathy Disease state
1
GLI60 Cell line
1
Baseline uninfected Disease state
1
Gastric cancer Disease state
1
Serum starvation synchronizati... Growth condition
1
Benign nevi Disease state
1
Astrocyte Cell type
1
MDS-associated acute myeloid l... Disease state
1
Acute myeloid leukemia Disease state
1
None Light
1
Uninfected control RNAi
1
Met5A Cell line
1
Pituitary Organism part
1
BC-1 Cell line
1
T3bN1M0 Disease staging
1
Cyclosporin A, mycophenolate m... Clinical treatment
1
Sirolimus, mycophenolate mofet... Clinical treatment
1
Carboplatin resistant Test result
1
Carboplatin sensitive Test result
1
Trigeminal ganglion Organism part
1
Acute malaria, natural infecti... Disease state
1
Kaposi's sarcoma Disease state
1
T84 Cell line
1
Vanadium pentoxide Compound treatment
1
No induction Protocol type
1
5-aza-2'-deoxycytidine Compound treatment
1
Well-functioning transplant Clinical info
1
Testis - interstitial Organism part
1
CodeLink Labeling Protocol type
1
Bone marrow Organism part
1
MCF7 Cell line
1
T3bN0M0 Disease staging
1
Breast cancer Disease state
1
Cervical cancer Disease state
1
Chloroguine Compound treatment
1
Mature monocyte derived dendri... Cell type
1
Measles virus Chicago-1 strain Infection
1
M-CSF Compound treatment
1
Hydrogen peroxide Compound treatment
1
Primary Disease staging
1
M2 macrophage Cell type
1
Refractory anemia with ringed ... Clinical info
1
IL-4 Compound treatment
1
Waldenstrom's macroglobulinemi... Disease state
1
MM1 Cell line
1
HTERT/HPVE6/HPVE7/SV40t/hRas t... Gene modification
1
Anaplasma phagocytophilum Infection
1
ITM-E6E7 Cell line
1
Primary fibroblast Cell type
1
Camptothecin Compound treatment
1
Down syndrome Disease state
1
Johnsen score count 2: Sertoli... Histology
1
Cystic change Histology
1
Primary bone marrow CD34+ stem... Cell type
1
White blood cell Cell type
1
Platelet Cell type
1
GLI72 Cell line
1
Central memory CD4 T cell Target cell type
1
Expression Profiles
E-GEOD-5258: Transcription profiling of human cell lines freely cycling treated with 164 distinct small molecules - Broad Connectivity Map CMAP Set 1
Experimental Factors
Show expression profile  /  experiment details

 
E-GEOD-5824: Transcription profiling of human Acute Lymphoblastic Leukemia CEM_C1 cells treated with rapamycin identifies rapamycin as a glucocorticoid resistance reversal agent
Experimental Factors
Phenotype Time Clinical info Dose Compound treatment
Show expression profile  /  experiment details

 
E-GEOD-4646: Transcription profiling of human HUVEC cells infected with Neisseria meningitidis wild type and mutants vs uninfected sampled at 3 time points
Experimental Factors
Time Infection
Show expression profile  /  experiment details

 
E-GEOD-4290: Transcription profiling of human glioma tumor samples
Experimental Factors
Disease state Tumor grading
Show expression profile  /  experiment details

 
Processing time: 0.14 secs.